ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BB04 | B | Cladribine - 10mg | 10977/945 | 15522/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 186,970,904 L.L | 2.44 | E2 | Merck Europe BV | The Netherlands | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01BB04 | B | Cladribine - 10mg | 9538 | 29118/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 3,066,779 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | |
L01BB04 | B | Cladribine - 10mg | 9539 | 29218/1 | MAVENCLAD | 10mg | 4 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 14,965,405 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | |
L01BB04 | B | Cladribine - 10mg | 9540 | 29318/1 | MAVENCLAD | 10mg | 6 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 22,449,959 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | |
L01BB04 | B | Cladribine - 10mg | 10977 | 15522/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 3,066,779 L.L | 2.44 | E2 | Merck Europe BV | The Netherlands | 2/5/2024 | |
L01BB04 | B | Cladribine - 10mg | 9538/945 | 29118/1 | MAVENCLAD | 10mg | 1 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 186,970,904 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | 0 |
L01BB04 | B | Cladribine - 10mg | 9539/945 | 29218/1 | MAVENCLAD | 10mg | 4 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 912,389,277 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | 0 |
L01BB04 | B | Cladribine - 10mg | 9540/945 | 29318/1 | MAVENCLAD | 10mg | 6 | Tablet | Oral | Food & Drug Corporation FDC | R-Pharm Germany GmbH | Germany | 1,368,696,863 L.L | 2.44 | E2 | Merck Serono Europe Ltd | UK | 2/5/2024 | 0 |